| Naslov: | Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice |
|---|
| Avtorji: | ID Cherrez-Ojeda, Ivan (Avtor)
ID Bousquet, Jean (Avtor)
ID Giménez-Arnau, Ana M. (Avtor)
ID Godse, Kiran V (Avtor)
ID Krasowska, Dorota (Avtor)
ID Bartosińska, Joanna (Avtor)
ID Szczepanik-Kułak, Paulina (Avtor)
ID Wawrzycki, Bartłomiej (Avtor)
ID Kolkhir, Pavel (Avtor)
ID Allenova, Anastasiia (Avtor)
ID Košnik, Mitja, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor), et al. |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S2213219824003490?via%3Dihub
 PDF - Predstavitvena datoteka, prenos (319,40 KB)
MD5: 56B0761CFB3373CB304C19E143D97FA0
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
|---|
| Povzetek: | Background
Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. They are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU) in clinical practice, but there are unmet needs and knowledge gaps regarding their use in clinical practice.
Objecctive
We investigated the global real-world use of AD and CU PROMs in allergology and dermatology clinics as well as their associated local and regional networks.
Methods
Across 72 specialized allergy and dermatology centers and their local and regional networks, 2,534 physicians in 73 countries completed a 53-item questionnaire on the use of PROMs for AD and CU.
Results
Of 2,534 physicians, 1,308 were aware of PROMs. Of these, 14% and 15% used PROMs for AD and CU, respectively. Half of physicians who use PROMs do so only rarely or sometimes. Use of AD and CU PROM is associated with being female, younger, and a dermatologist. The Patient-Oriented Scoring Atopic Dermatitis Index and Urticaria Activity Score were the most common PROMs for AD and CU, respectively. Monitoring disease control and activity are the main drivers of the use of PROMs. Time constraints were the primary obstacle to using PROMs, followed by the impression that patients dislike PROMs. Users of AD and CU PROM would like training in selecting the proper PROM.
Conclusions
Although PROMs offer several benefits, their use in routine practice is suboptimal, and physicians perceive barriers to their use. It is essential to attain higher levels of PROM implementation in accordance with national and international standards. |
|---|
| Ključne besede: | allergy, atopic dermatitis, chronic urticaria, dermatology, patient reported outcome measures |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 20.11.2023 |
|---|
| Datum sprejetja članka: | 26.03.2024 |
|---|
| Datum objave: | 06.04.2024 |
|---|
| Založnik: | Elsevier |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 1575-1583.e1 |
|---|
| Številčenje: | Vol. 12, iss. 6 |
|---|
| Izvor: | The journal of allergy and clinical immunology. In practice |
|---|
| PID: | 20.500.12556/DiRROS-22836  |
|---|
| UDK: | 616-097 |
|---|
| ISSN pri članku: | 2213-2201 |
|---|
| DOI: | 10.1016/j.jaip.2024.03.050 |
|---|
| COBISS.SI-ID: | 194003971 |
|---|
| Avtorske pravice: | © 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/). (J Allergy Clin Immunol Pract 2024;12:1575-83) |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Soavtor iz Slovenije: Mitja Košnik ;
Opis vira z dne 26. 4. 2024;
|
|---|
| Datum objave v DiRROS: | 02.07.2025 |
|---|
| Število ogledov: | 395 |
|---|
| Število prenosov: | 242 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
